Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feedergoogle.co.in
Get the latest updates from Google Alert - omalizumab directly as they happen.
Follow now 114 followers
Last updated about 9 hours ago
about 15 hours ago
Omalizumab is a humanized monoclonal IgG1 antibody approved by the US-FDA for...
1 day ago
... omalizumab showed the highest complete response rate at 37.5%. METHODOLOGY: Researchers...
1 day ago
... omalizumab in urticaria, and more. Phase 3 Trial Confirms Roflumilast's Dual-Site...
1 day ago
Efficacy of Omalizumab in a Patient with Angioedema Clinically Resembling a Hereditary...
1 day ago
... (omalizumab). The biosimilar targets treatments for severe persistent allergic asthma and...
2 days ago
MEPOLIZUMAB IS NOT INFERIOR TO OMALIZUMAB, IMPROVING ASTHMA CONTROL IN SEVERE ALLERGIC...
2 days ago
Omalizumab, a biologic for moderate-to-severe persistent asthma, received recent approval for FA...
2 days ago
... to dermatological procedures, adverse effects of omalizumab in urticaria, and more.
2 days ago
W Polsce dostępnych jest pięć leków biologicznych: omalizumab, mepolizumab, benralizumab, dupilumab i...
2 days ago
CT-P39 is Just as Effective as Omalizumab for Chronic ...
3 days ago
Omalizumab: It is a humanized anti-IgE monoclonal antibody, which is suitable for...
3 days ago
Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to...